Skip to main content
. 2023 Nov 22;6(4):805–827. doi: 10.20517/cdr.2023.77

Figure 8.

Figure 8

(A) Schematic illustration of TTNDV to overcome cancer drug resistance by killing n-DNA and Mt-DNA; (B) Tumor growth inhibition curves of tumor-bearing mice after different formulations (*P < 0.05). This figure is quoted with permission from Nair et al.[114]. DOX: Doxorubicin; FA: folic acid.